Jukka Westermarck and his group received the Elias Tillandz -prize
Prof. Jukka Westermarck and his group received the Elias Tillandz -prize for the best publication of the year for his ground-breaking study on that reveals the druggability of type-2A phosphatase, which has been largely regarded as a non-druggable cancer target. Link to study.
Warmest congratulations to the whole team!
Read more:
Recent Posts
-
Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetes
An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important Read moreJanuary 20, 2026
-
Turku Bioscience Centre Is Recruiting New Research Leaders
Turku Bioscience Centre is currently inviting applications for two key research positions that will strengthen Read moreJanuary 13, 2026
-
Season’s Greetings & Happy 2026!
Season’s Greetings & Happy 2026! From everyone at Turku Bioscience. Riitta Lahesmaa,Director of Turku Bioscience Read moreDecember 23, 2025
-
The Sigrid Jusélius senior researcher posts grant to Carlos Rogerio Figueiredo
The Sigrid Jusélius Foundation has awarded a four-year senior researcher grant of €700,000 to our Read moreDecember 15, 2025
-
Guillaume Jacquemet awarded the 2025 Chancellor’s Prize
Guillaume Jacquemet, a Group Leader at our centre, has been awarded the Chancellor’s Prize for Read moreDecember 15, 2025
-
New Funding for our Centre’s Researchers
Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025